Protect Patient Access to Low-Dose Radiation Therapy
An insurance review change is coming in November 2026. Here is what it means for you, and how you can help.
What is changing
Many insurance plans hand radiation therapy approvals to an outside review company called eviCore. That includes many Cigna plans and some other commercial and Medicare Advantage plans.
eviCore has announced that, beginning in November 2026, it plans to treat low-dose radiation therapy for benign conditions as not medically necessary. Osteoarthritis and plantar fasciitis are named, and tendinitis and tendinopathy are expected to be affected too.
Radiation oncology societies have asked eviCore to reconsider. So far it has declined.
What it means for you
The change applies only to plans that use eviCore for radiation review. We verify your benefits before treatment, so there are no surprises. If you are not sure whether your plan uses eviCore, call us and we will check for you.
If you have already been told low-dose radiation therapy is not covered, please call us anyway. Every plan is different, and we will tell you exactly where you stand.
How you can help
The Radiotherapy Access Alliance is a not-for-profit organization founded by practicing radiation oncologists and medical physicists. Its goal is to protect patient access to medically indicated radiation therapy through advocacy, education, and legal action.
You can also help by sharing your story. If low-dose radiation therapy helped you, the Alliance would like to hear about it through its website.
The Radiotherapy Access Alliance is an independent organization. Its 501(c)(6) application is pending, and donations to it are generally not tax-deductible as charitable gifts.